against cellular-including tumour-antigens, and probably many cases of supposed tolerance are due to blocking or enhancing antibodies.
Leukaemogenic Viruses
The second group of naturally occurring oncogenic viruses in mice is the leukaemogenic viruses. Most mouse strains carry leukaemogenic viruses related to Gross virus, which are transmitted vertically from mothers (and sometimes from fathers) to offspring. For many years it was thought that animals were tolerant to such viruses, producing neither antibody nor cell-mediated immunity. If that were the case, immunosuppression would not be expected to affect tumour development. In fact, it does. Thymectomy cannot be used in this situation, because the production of leukaemia by both the Gross and the Moloney virus requires the presence of a thymus. However, Allison and Law7 found that Moloney lymphoma or leukaemia was greatly potentiated by inoculations of antilymphocytic serum. We have found that the latent period for leukaemia induction in AKR mice, which carry the Gross virus, is shortened by the administration of antilymphocytic serum.
Wahren and Metcalfe"2 have found that lymphocytes from AKR mice are cytotoxic to target cells carrying the Gross virus, so that they can no longer be regarded as tolerant. Other evidence that this is so has been presented by Dore et al.13 In this case nearly all animals left long enough develop leukaemia (after a latent period of about 300 days). Immunity does not prevent leukaemia but delays its onset, which allows the animals to breed before onset of malignancy. Immunosuppression accelerates the malignancy.
Immunological Surveillance
All these results leave little doubt that the immunological surveillance mechanism operates very efficiently against virusinduced tumours in animals, either preventing or delaying the onset of malignancy. All the tumours so far found in mice receiving long-term immunosuppression have been leukaemias, lymphomas, or mammary tumours, or polyomainduced tumours of the salivary glands or osteosarcomas. In all these cases there is reason to believe that a virus may be concerned in the aetiology. Though the surveillance mechanism may also operate against tumours not induced by viruses, there is no direct evidence that this is the case.
Nevertheless, 'it would be premature to conclude that the tumours occurring in human patients treated with immunosuppressants are virus-induced, though the parallel between animals is striking enough to demand further analysis.
Immunosurveillance and Cancer: Epidemiological Evidence R. DOLL,* O.B.E., F.R.C.P., F.R.S., and L. KINLENt M.B., B.S., M.R.C.P. British Medical J3ournal, 1970, 4, 420-422 The mechanism by which cancer develops remains one of the great mysteries of modern medicine. The concept that it results from a breakdown in "immunological surveillance," which permits the proliferation of an abnormal clone of cells with a selective advantage over other cells, has been widely welcomed as a stimulus to thought and experiment. Keast' has recently summarized the evidence for this hypothesis under four heads. Firstly, cancer in man occurs characteristically at the extremes of life when the immune system is either maturing or is weakened by thymic atrophy. Secondly, its incidence is increased following the use of immunosuppressive drugs. Thirdly, the same effect is produced experimentally by thymectomy in mice. Fourthly, the rare diseases that involve a deficiency of cell-mediated immunity are characterized by a high incidence of tumours in those subjects who survive long enough to allow their development.
In the present paper we review only those parts of the evidence that have been obtained from observations on man. Table) . 
Immunological Disorders

Age Distribution of Cancer
The age distribution of cancer is sometimes cited as evidence of an association with defective immunological control. Certainly, the two common patterns are (1) a peak incidence in infancy or childhood, and (2) a rapid, uninterrupted, and fairly regular increase in incidence from adolescence to old age. There is, however, a wide variety of patterns between M these extremes. Cancers like seminoma of the testis and some varieties of Hodgkin's disease show a peak incidence in young adult life. Others like carcinoma of the corpus uteri decrease in incidence in old age, while the incidence of carcinoma of the cervix uteri remains practically constant after about 45 years of age. Explanations can be found for most of these patterns, but the fact remains that there are as many exceptions to the two "typical" patterns as there are examples.
Examination of the pattern of age-specific incidence rates of those cancers that increase in incidence with age shows that the incidence increases approximately in proportion to a power of the age, commonly the fourth, fifth, or sixth power. This pattern is not limited to cancer and is shown by other degenerative diseases, which, it may be argued, provides evidence that they are all related to some nonspecific process of ageing. More detailed examination suggests, however, that the increase in incidence may depend not so much on age as such as on the duration of exposure to a carcinogenic agent, and that the most characteristic pattern is one in which incidence is proportional to about the fourth power of the duration of exposure. This pattern, for example, is shown both by bronchial carcinoma in cigarette smokers and by skin cancer in mice which have been painted at regular intervals with one or other of several carcinogenic agents.'
Age at Exposure
Most sources of data available show that the incidence of cancer increases with age at exposure. The clearest evidence derives from patients who have been irradiated for ankylosing spondylitis, among whom the incidence of leukaemia attributable to irradiation increased from approximately 2-7 per 1,000 in patients irradiated at ages 15 to 24 years to 10-6 per 1,000 among patients irradiated at ages 60-69 years.'718 Other evidence derives from a group of men who were employed in a nickel refinery in South Wales before 1925, 40 of whom (8%) developed cancer of the nasal sinuses. After allowance was made for date and duration of exposure the incidence was found to increase four-fold between men whose ages at first employment were respectively under 20 years of age and 35 years or more."9 Three other industries have also provided similar observations relating to the incidence of tar-warts in men who made gas from coal,"0 " cancer of the lung in asbestos workers,22 and cancer of the bladder in chemical workers exposed to /3-naphthylamine, a-naphthylamine, or benzidine.23
Two sets of data, however, provide results which point in a different direction. Firstly, Bizzozero et alit found that the incidence of leukaemia among the Japanese who survived exposure to the atomic bomb explosions at Hiroshima and Nagasaki and who were within 1,500 metres of the hypocentre of the explosion, was unrelated to age, except for a somewhat higher incidence in those who were less than 10 years old at the time of exposure. Secondly, the incidence of occupational cancers of the lung in nickel workers increased with age at first employment only up to 25 years of age and then fell. "9 These studies are all based on substantial numbers and the difference between the results cannot be attributed to chance; nor can it be attributed to a difference in the extent to which men and women of different ages were exposed to the carcinogenic agent. Indeed, the conflicting observations for cancers of the lung and nasal sinuses were made on the same group of men. One possible explanation is that the effect of age on the susceptibility to cancer induction is not always the same but varies with the extent to which the tissue has already been exposed to other agents. '7 Be that as it may, we cannot use the present data to support the hypothesis that the appearance of cancer is determined to any important extent by an ageing process that is independent of the amount and duration of exposure to carcinogenic agents.
Conclusion
We must conclude that the four sources from which Keast' sought evidence provide only very weak support for the idea that the appearance of clinical cancer is generally the result of a breakdown in immunological surveillance. That is not to say that the idea is wrong, nor that immune mechanism cannot be utilized effectively for treatment of established disease. The evidence that we have reviewed points to a close association between immunological disorders and the development of cancers of the reticuloendothelial system, but this does not necessarily imply cause and effect. Both may be due to a common cause. A key question is whether intensive immunosuppression will lead to an increased frequency of other types of cancer and whether this is so or not remains to be seen.
